An exploratory study of the efficacy and safety of yokukansan for postoperative delirium in patients who underwent surgical resection of malignant tumor of digestive system.
Not Applicable
- Conditions
- Digestive system cancer
- Registration Number
- JPRN-UMIN000013235
- Lead Sponsor
- Hitachi,Ltd.,Hitachi General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who require emergency surgery. 2)Patients with severe complications, including cardiac, renal, blood or lung diseases, or with other complications judged to be life-threatening. 3)Patients administered antipsychotic agents and therapeutic agents for dementia. 4)Patients administered Kampo medicines other than the study drug. 5) Patients who were judged to be inappropriate as subjects by the study investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method